Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAP: Low Dose Aspirin for Birthweight in Twins
NCT02280031Phase 2Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in preeclampsia, fetal growth restriction (FGR), preterm birth, Small for gestational age (SGA), sponsored by CHU de Québec-Université Laval. Started Nov 2014; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiafetal growth restriction (FGR)preterm birthSmall for gestational age (SGA)
Beyond the preview
Go deeper on NCT02280031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280031.